Search





Search





Markets
/
Stocks
/
syre
/

Spyre Therapeutics Inc

SYRE

Add to Watchlist

98.330USD

-3.170-3.12%

Close 07-31 16:00（ET）Quotes delayed by 15 min

8.54BMarket Cap

LossP/E TTM

Spyre Therapeutics Inc

98.330

-3.170-3.12%

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Overview

Financials

Discussions

Analysis

Company

TradingKey Stock Score Overall Financial Health Valuation Dimensions Earnings Forecast Price Momentum Institutional Confidence Risk Assessment

Institutional Confidence

Currency: USD Updated: 2026-07-31

Previous score

10.00

Change

The current institutional shareholding score of Spyre Therapeutics Inc is 10.00, ranking 1 out of 385 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 103.37%, representing a quarter-over-quarter increase of 19.72%. The largest institutional shareholder is ETHSX, holding a total of 13.79K shares, representing 0.03% of shares outstanding, with 200.00% increase in holdings.

Institutional Shareholding

Shareholder Activity

Name

Shares Held

Chg %

Fidelity Management & Research Company LLC

11.53M

+28.52%

BlackRock Institutional Trust Company, N.A.

4.99M

+39.08%

Perceptive Advisors LLC

3.07M

+149.64%

RTW Investments L.P.

4.17M

+15.18%

Fairmount Funds Management LLC

4.02M

VR Adviser, LLC

3.69M

+37.24%

Deutsch (Peter E)

3.55M

+825.37%

Capital International Investors

3.49M

+45.98%

Driehaus Capital Management, LLC

2.88M

+39.90%